| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $22.5M | +31.2% |
| SG&A Expense | $12.1M | +23.4% |
| Operating Income | -$34.6M | -28.4% |
| Interest Expense | $1.6M | +26.2% |
| Income Tax | $0 | — |
| Net Income | -$35.7M | -26.2% |
| EPS (Basic) | -$3.09 | +58.6% |
| EPS (Diluted) | -$3.09 | +58.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.2M | -39.7% |
| Current Assets | $33.0M | -52.2% |
| Total Assets | $46.1M | -37.1% |
| Current Liabilities | $7.3M | -63.7% |
| Long-term Debt | $10.4M | -31.0% |
| Total Liabilities | $28.0M | -24.6% |
| Stockholders' Equity | $18.1M | -49.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.1M | -19.7% |
| Capital Expenditures | $562K | +316.3% |
| Investing Cash Flow | -$562K | -479.4% |
| Financing Cash Flow | $11.4M | -80.7% |
| Free Cash Flow | -$31.6M | -21.2% |